Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Michiels

Showing results (1-10 of 250) with videos related to

Pageof 25
Sort By:
The New England Journal of Medicine|April 13, 2007
Five-gene signature in non-small-cell lung cancerStefan Michiels, Catherine Hill
Medecine Sciences : M/S|March 13, 2008
[The statistical challenge of false positives with microarrays]Stefan Michiels, Catherine Hill
European Journal of Cancer (Oxford, England : 1990)|November 4, 2019
Overestimated treatment effects in randomised phase II trials: What's up doctor?Stefan Michiels, James Wason
Current Opinion in Oncology|March 12, 2013
Omics-based clinical trial designsMarc Buyse, Stefan Michiels
The Lancet. Global Health|July 18, 2018
All simulation models of breast cancer are wrong but some are usefulStefan Michiels, Suzette Delaloge
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Clinical usefulness of microarrays for cancer prognosis in 2010--letterSerge Koscielny, Stefan Michiels
BMC Medical Research Methodology|June 3, 2014
Testing the treatment effect on competing causes of death in oncology clinical trialsFederico Rotolo, Stefan Michiels
Molecular Oncology|February 26, 2011
Multidimensionality of microarrays: statistical challenges and (im)possible solutionsStefan Michiels, Andrew Kramar, Serge Koscielny
Pharmacogenomics|January 11, 2011
A time series evaluation of the in vivo effect of letrozole on gene expression in breast cancerDebora Fumagalli, Stefan Michiels, Christos Sotiriou
Bioinformatics (Oxford, England)|September 21, 2017
biospear: an R package for biomarker selection in penalized Cox regressionNils Ternès, Federico Rotolo, Stefan Michiels
Pageof 25

Showing results (1-10 of 250) with videos related to

Sort By:
Pageof 25
The New England Journal of Medicine|April 13, 2007
Five-gene signature in non-small-cell lung cancerStefan Michiels, Catherine Hill
Medecine Sciences : M/S|March 13, 2008
[The statistical challenge of false positives with microarrays]Stefan Michiels, Catherine Hill
European Journal of Cancer (Oxford, England : 1990)|November 4, 2019
Overestimated treatment effects in randomised phase II trials: What's up doctor?Stefan Michiels, James Wason
Current Opinion in Oncology|March 12, 2013
Omics-based clinical trial designsMarc Buyse, Stefan Michiels
The Lancet. Global Health|July 18, 2018
All simulation models of breast cancer are wrong but some are usefulStefan Michiels, Suzette Delaloge
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Clinical usefulness of microarrays for cancer prognosis in 2010--letterSerge Koscielny, Stefan Michiels
BMC Medical Research Methodology|June 3, 2014
Testing the treatment effect on competing causes of death in oncology clinical trialsFederico Rotolo, Stefan Michiels
Molecular Oncology|February 26, 2011
Multidimensionality of microarrays: statistical challenges and (im)possible solutionsStefan Michiels, Andrew Kramar, Serge Koscielny
Pharmacogenomics|January 11, 2011
A time series evaluation of the in vivo effect of letrozole on gene expression in breast cancerDebora Fumagalli, Stefan Michiels, Christos Sotiriou
Bioinformatics (Oxford, England)|September 21, 2017
biospear: an R package for biomarker selection in penalized Cox regressionNils Ternès, Federico Rotolo, Stefan Michiels
Pageof 25